Estimated read time 1 min read
Posted in Medicine

EU regulator backs approval for ARS Pharma's nasal spray alternative to EpiPen – Reuters

admin

  1. EU regulator backs approval for ARS Pharma’s nasal spray alternative to EpiPen  Reuters
  2. ARS Pharmaceuticals On Track With Neffy Despite Regulatory Hurdles (NASDAQ:SPRY)  Seeking Alpha
  3. First Nasal Adrenaline Spray for Anaphylaxis Backed by EMA  Medscape
  4. ARS Pharmaceuticals Gets CHMP Backing for…

[ad_2]

Source link

You May Also Like

More From Author

28 Products For Anyone Working Out Indoors This Summer – BuzzFeed

In setback, Steward and Optum walk away from deal for physician network

Leave a Reply

Your email address will not be published. Required fields are marked *